Cardiovascular Research Advance Access originally published online on September 10, 2008
Cardiovascular Research 2008 80(2):163-164; doi:10.1093/cvr/cvn245
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org
Activating SIRT1: a new strategy to prevent atherosclerosis?
Institut für Kardiovaskuläre Physiologie, Goethe-Universität, Theodor-Stern-Kai 7, D-60596 Frankfurt am Main, Germany
* Corresponding author. Tel: +49 69 6301 6995; fax: +49 69 6301 7668. E-mail address: r.brandes@em.uni-frankfurt.de
This editorial refers to Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice by Zhang et al.,8 pp. 191–199, this issue.
| The first 10% of the full text of this article appears below. |
The development of atherosclerosis is a complex, multi-step process, which is at least in part controlled by the functional state of the vascular endothelium. It is generally believed that the functional state of the endothelium is influenced by a broad set of cardiovascular risk factors and that endothelial dysfunction is the stereotypic cellular response to a broad range of different stimuli on the background of a poorly defined genetic predisposition.1
That such a concept represents an over-simplification
Related Article
![]()
CiteULike
Connotea
Del.icio.us What's this?
Cardiovasc Res 2008 80: 191-199.